The identification of mutations in Tau as the cause of some of these tauopathies (e.g. FTDP-17 frontotemporal lobar degeneration with Tau inclusions) has further indicated the important role of this protein in neurodegeneration (Frost et al., 2015). The gene discussed is MAPT; the disease is tauopathy.